Biological Sciences and Healthcare, part 4

... > Clinical finding (finding) > disease > Disorder of body system > Disorder of hematopoietic structure (disorder) > Bone marrow disorder > Myeloproliferative disorder (disorder) > Myeloid leukemia > Acute myeloid leukemia > Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) > Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent > Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent

... > Clinical finding (finding) > disease > Disorder of hematopoietic cell proliferation (disorder) > Myeloproliferative disorder (disorder) > Myeloid leukemia > Acute myeloid leukemia > Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) > Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent > Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent

... > Clinical finding (finding) > disease > Neoplasm and/or hamartoma (disorder) > Neoplastic disease > Malignant tumour > Malignant neoplasm of lymphatic and haemopoietic tissue > Leukaemia > Myeloid leukemia > Acute myeloid leukemia > Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) > Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent > Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent

... > Clinical finding (finding) > disease > Neoplasm and/or hamartoma (disorder) > Neoplastic disease > Neoplasm of hematopoietic cell type (disorder) > Malignant neoplasm of lymphatic and haemopoietic tissue > Leukaemia > Myeloid leukemia > Acute myeloid leukemia > Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) > Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent > Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent

... > Clinical finding (finding) > disease > Disorder of body system > Disorder of hematopoietic structure (disorder) > Neoplasm affecting hematopoietic structure (disorder) > Leukaemia > Myeloid leukemia > Acute myeloid leukemia > Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) > Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent > Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent

... > Clinical finding (finding) > disease > Disorder of body system > Hematologic neoplasm > Neoplasm affecting hematopoietic structure (disorder) > Leukaemia > Myeloid leukemia > Acute myeloid leukemia > Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) > Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent > Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent

... > Clinical finding (finding) > disease > Neoplasm and/or hamartoma (disorder) > Neoplastic disease > Hematologic neoplasm > Neoplasm affecting hematopoietic structure (disorder) > Leukaemia > Myeloid leukemia > Acute myeloid leukemia > Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) > Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent > Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent

... > Clinical finding (finding) > disease > Neoplasm and/or hamartoma (disorder) > Neoplastic disease > Malignant tumour > Malignant neoplasm of lymphatic and haemopoietic tissue > Leukaemia > Acute leukemia > Acute myeloid leukemia > Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) > Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent > Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent

... > Clinical finding (finding) > disease > Neoplasm and/or hamartoma (disorder) > Neoplastic disease > Neoplasm of hematopoietic cell type (disorder) > Malignant neoplasm of lymphatic and haemopoietic tissue > Leukaemia > Acute leukemia > Acute myeloid leukemia > Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) > Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent > Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent

... > Clinical finding (finding) > disease > Disorder of body system > Disorder of hematopoietic structure (disorder) > Neoplasm affecting hematopoietic structure (disorder) > Leukaemia > Acute leukemia > Acute myeloid leukemia > Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) > Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent > Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent

... > Clinical finding (finding) > disease > Disorder of body system > Hematologic neoplasm > Neoplasm affecting hematopoietic structure (disorder) > Leukaemia > Acute leukemia > Acute myeloid leukemia > Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) > Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent > Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent

... > Clinical finding (finding) > disease > Neoplasm and/or hamartoma (disorder) > Neoplastic disease > Hematologic neoplasm > Neoplasm affecting hematopoietic structure (disorder) > Leukaemia > Acute leukemia > Acute myeloid leukemia > Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) > Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent > Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent